LEVETIRACETAM STRAGEN 500 mg/100 ml, solution for infusion 10 bags of 100 ml
Active ingredients: (S)-etiracetam
Commercialized according to BDPMDispensing in France: Prescription only
Solution for infusion10 bags of 100 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LEVETIRACETAM STRAGEN 500 mg/100 ml, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 poche(s) polyoléfine avec 2 connecteurs suremballée(s)/surpochée(s) de 100 ml
- Marketing authorisation holder
- STRAGEN-FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 24 May 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68588624CIP75500023CIP133400955000235Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVÉTIRACÉTAMsolution | 5 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.